Baxter International Inc. (NYSE: BAX) – For an in-depth report on Baxter International Inc. follow: www.BullTrends.com/stockquote/BAX
BAX shares closed up 3.88% on Thursday with nearly 20 million shares traded. The stock was one of the most active stocks on the NYSE and hit an all-time high of $75.68 during intra-day trading. The big gain came after the company announced it plans to split into two separate businesses by mid-2015 pending approval from Baxter's board of directors.
Spherix Incorporated (NASDAQ: SPEX) - For an in-depth report on Spherix Incorporated follow: www.BullTrends.com/stockquote/SPEX
Shares of Spherix closed down 23.44% with about 2 million shares traded on Thursday. The stock was one of the biggest decliners on the NASDAQ. The company filed a lawsuit against Cisco Inc alleging infringement of 11 patents Spherix acquired from Nortel Networks. Spherix said the infringement accounted for a "vast majority" of Cisco's more than $43 billion in sales of routers and switches in the United States over the five years ended July 27, 2013.
ContraVir Pharmaceuticals, Inc. (OTCBB: CTRV) - For an in-depth report on ContraVir Pharmaceuticals, Inc. follow: www.BullTrends.com/stockquote/CTRV
Shares of CTRV closed down nearly 12% on Thursday with about 200,000 shares traded. The stock was one of the most active stocks traded in the OTCBB market. The biopharmaceutical company, develops drugs to treat herpes zoster (HZ) disease. It is involved in the clinical development of FV-100 to treat HZ or shingles, which is an infection, caused by the reactivation of varicella zoster virus (VZV) or chickenpox.
Globalstar Inc. (OTC: GSAT) - For an in-depth report on Globalstar Inc. follow: www.BullTrends.com/stockquote/GSAT
Shares of GSAT closed down a modest 3.50% on about 5 million shares traded on Thursday. The stock was one of the most active stocks in the OTC marketplace despite any news released from the company. The company provides mobile voice and data communications services through satellite worldwide.
Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.